This week, three profitable Chinese companies will attempt to take advantage of the recent interest and confidence investors have shown in the IPO markets: a solar module provider, a cancer center operator and a biopharmaceutical company will all come to market within the next few days as IPO activity levels surge before the year end.
Trony Solar Holdings (TRO), which provides solar photovoltaic (PV) modules, is planning to raise $195 million by offering 19.5 million ADSs (including 4.5 million from insiders) at a price range of $9.00 to $11.00.
Concord Medical Services Holdings (CCM) is a leading operator of radiotherapy and diagnostic imaging centers in China. The company plans to raise $126 million by offering 12 million ADSs at a revised price range of $9.50 to $11.50, up from its original range of $9.00 to $11.00.
China Nuokang Bio-Pharmaceutical (NKBP), which sells 14 hematological and cardiovascular products, plans to offer 5 million ADSs, including 473,000 from selling shareholders, at a price between $10 and $12 per share.
For more details on these upcoming IPOs, please read our full IPO Commentary.
